MasterPlans is a 10-year-old business plan writing company located in Portland, Oregon. To contact us, call 1-877-453-2011 or email info@masterplans.com.
button preload
button preload

MasterPlans: The business plan experts. Custom business plans by professional business plan writers. Business plan consulting by professional business plan consultants.

More Money: Funding Manna.

As you may have already heard today, March wasn’t such a hot month for the job market. But we’ll get to that later today. First, the good news: plenty of start-ups received healthy chunks of capital this week. Here’s who secured funding:

-Recession what? Biotech firm BioVex announced this week that they’ve secured $40 million in funding, reports the Boston Globe. This brings their total funding to date to $120 million. Bio Vex, which develops anti-cancer drugs, says they’ll use this new round of investment to fund phase 3 clinical trials of OncoVex, “a cancer-destroying vaccine,” that’s targeted for use with skin cancer patients.

-Livescribe, a company we wrote about a few months ago, has secured another round of funding, this time to the tune of $7.5 million, according to Yahoo Finance. The start-up, which makes a “smart pen,” has raised a total of $18.6 million in funding this quarter alone. That’s impressive by anyone’s standards.

-It’s not often we write about venture capital firms themselves raising capital, but it’s indeed how many venture firms support themselves in times of low liquidity (translation: right now). This week Charles River Ventures, a VC firm that’s invested in the likes of Twitter, raised $320 million. This is the firm’s 14th fund, according to VentureBeat.

-Pliant Technology, a start-up that develops enterprise flash drives, announced Monday that they secured $15 million in series C funding, reports RTT News. They say they’ll use the investment as working capital to support their growth. Who says you can’t grow in this economy?

-Pathway Medical Technologies, a biotech firm, announced Monday that they negotiated $40 million in series D funding from a group of at least five investors. The company develops treatments for peripheral arterial disease, and will use the new money to bolster their sales team and augment product development—the usual.

-MicroTransponder, a start-up that develops wireless systems for patients in chronic pain, nailed $2.2 million in funding this week, reports Fox Business News

-AirSage, a company that uses cell phone data to map traffic flow and travel times, has secured $2.5 million in funding from angel investors in (oddly) Switzerland and Atlanta. So far the company has raised $15 million, and they say they’ll use this new round to boost sales, although they’re already doing quite well. They recently signed Google Maps as a client.

airsage

Leave a Reply

Follow us on Twitter

All posts come from our CEO, Bryan Howe.

Like us on Facebook for free tools and articles. We have over 10,000 "likes"!
BusinessWeekBusinessWeekEO PortlandEO PortlandPortland Business JournalPortland Business JournalInc. 500Inc. 500EntrepreneurEntrepreneurWall Street JournalWall Street JournalBetter Business BureauBetter Business BureauAuthorize.netMasterPlans Facebook pageMasterPlans Facebook page
© 2000–2013
0